NeoGenomics, Inc. (NEO)
13.16
+0.33
(+2.57%)
USD |
NASDAQ |
Jan 09, 16:00
13.18
+0.02
(+0.11%)
After-Hours: 20:00
NeoGenomics Profit Margin (Quarterly): -14.45% for Sept. 30, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| IQVIA Holdings, Inc. | 8.10% |
| Incyte Corp. | 31.05% |
| Regeneron Pharmaceuticals, Inc. | 38.89% |
| Arcturus Therapeutics Holdings, Inc. | -95.02% |
| Fortrea Holdings, Inc. | -2.27% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -12.92% |
| Return on Assets | -7.42% |
| Return on Invested Capital | -8.07% |
| Gross Profit Margin (Quarterly) | 41.23% |
| Operating Margin (Quarterly) | -7.55% |
| Return on Net Operating Assets | -9.31% |